The advertisement promotes VYVGART Hytrulo, highlighting it as the first and only IgG4-antibody fragment for adults with anti-ACR antibody positive gMG, while also providing important safety information and contraindications.
Creative Information
| CID: | 0fcbdf64-2613-4fb5-8a6f-84805555ad89 |
| CRID: | 82_5970-959612 |
| Domain: | vyvgarthcp.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $0.34 |
| Timestamp: | 11/2/2025, 1:23:35 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/11/2025, 11:18:23 PM | 6.93s | |
| adomain_analysis | success | 11/12/2025, 12:29:40 AM | 3.00s | |
| adomain_capture | success | 11/12/2025, 12:29:27 AM | 0.07s | |
| ad_render | success | 11/11/2025, 11:18:16 PM | 25.00s | |
| brand_mapping | success | 11/11/2025, 10:32:06 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: VYVGART Hytrulo
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1289.71 KB | ||||||||||||||||||||||
| Render Time: | 9.53 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1358.11 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


